+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Alzheimer's Treatment Market Report and Forecast 2025-2034 - Product Thumbnail Image

Alzheimer's Treatment Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Multiple Sclerosis Market in US 2025-2029 - Product Thumbnail Image

Multiple Sclerosis Market in US 2025-2029

  • Report
  • December 2024
  • 139 Pages
  • United States
From
Neurology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Neurology Clinical Trials Market Report 2023-2033

  • Report
  • January 2023
  • 262 Pages
  • Global
From
From
Neurology Clinical Trials - Global Strategic Business Report - Product Thumbnail Image

Neurology Clinical Trials - Global Strategic Business Report

  • Report
  • July 2025
  • 385 Pages
  • Global
From
From
From
Stroke Management Market Report 2025 - Product Thumbnail Image

Stroke Management Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Neuroregeneration Therapy - Global Strategic Business Report - Product Thumbnail Image

Neuroregeneration Therapy - Global Strategic Business Report

  • Report
  • July 2025
  • 480 Pages
  • Global
From
Diabetic Neuropathy Market Report 2025 - Product Thumbnail Image

Diabetic Neuropathy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Loading Indicator